Cited by 137Telomeres, Telomerase, and SenescenceBone Metabolism and DiseasesAdipose Tissue and Metabolism

Oxylipin-PPARγ-initiated adipocyte senescence propagates secondary senescence in the bone marrow

Open access
Liu, Xiaonan, Gu, Yiru, Kumar, Surendra, Amin, Sahran, Guo, Qiaoyue, Wang, Jiekang, Fang, Ching-Lien, Cao, Xu +1 more·2023·Cell Metabolism

Abstract

The chronic use of glucocorticoids decreases bone mass and quality and increases bone-marrow adiposity, but the underlying mechanisms remain unclear. Here, we show that bone-marrow adipocyte (BMAd) lineage cells in adult mice undergo rapid cellular senescence upon glucocorticoid treatment. The senescent BMAds acquire a senescence-associated secretory phenotype, which spreads senescence in bone and bone marrow. Mechanistically, glucocorticoids increase the synthesis of oxylipins, such as 15d-PGJ2, for peroxisome proliferator-activated receptor gamma (PPARγ) activation. PPARγ stimulates the expression of key senescence genes and also promotes oxylipin synthesis in BMAds, forming a positive feedback loop. Transplanting senescent BMAds into the bone marrow of healthy mice is sufficient to induce the secondary spread of senescent cells and bone-loss phenotypes, whereas transplanting BMAds harboring a p16INK4a deletion did not show such effects. Thus, glucocorticoid treatment induces a lipid metabolic circuit that robustly triggers the senescence of BMAd lineage cells that, in turn, act as the mediators of glucocorticoid-induced bone deterioration.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cmet.2023.03.005

Cites

0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • PPARγ is a key transcription factor mediating p16Ink4a gene activation and BMAd senescence.

    “Previous studies revealed that PPARγ is a key transcription factor mediating p16Ink4a gene activation53 and BMAd senescence47.”
  • The majority of the elevated factors in this context differ from the SASP factors previously identified in glucocorticoid-induced senescent BMAds.

    “It is noteworthy that the majority of the elevated factors in this context differ from the SASP factors previously identified in glucocorticoid-induced senescent BMAds47.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 66

  1. [1]Li Z, Hardij J, Bagchi DP, Scheller EL, & MacDougald OA (2018). Development, regulation, metabolism and function of bone marrow adipose tissues. Bone, 110: 134– 140. 29343445 PMC6277028
  2. [2]Cawthorn WP, Scheller EL, Learman BS, Parlee SD, Simon BR, Mori H, Ning X, Bree AJ, Schell B, & Broome DT (2014). Bone Marrow Adipose Tissue Is an Endocrine Organ that Contributes to Increased Circulating Adiponectin during Caloric Restriction. Cell Metabolism, 20(2): 368– 375. 24998914 PMC4126847
  3. [3]Scheller EL, Burr AA, MacDougald OA, & Cawthorn WP (2016). Inside out: Bone marrow adipose tissue as a source of circulating adiponectin. Adipocyte, 5(3): 251– 269. 27617171 PMC5014002
  4. [4]Sulston RJ, & Cawthorn WP (2016). Bone marrow adipose tissue as an endocrine organ: close to the bone? Hormone Molecular Biology and Clinical Investigation, 28(1). 27149203
  5. [5]Horowitz MC, Berry R, Holtrup B, Sebo Z, Nelson T, Fretz JA, Lindskog D, Kaplan JL, Ables G, & Rodeheffer MS (2017). Bone marrow adipocytes. Adipocyte, 6(3): 193– 204. 28872979 PMC5638373
  6. [6]Blair HC, Robinson LJ, Sun L, Isales C, Davies TF, & Zaidi M (2011). Skeletal receptors for steroid-family regulating glycoprotein hormones. Annals of the New York Academy of Sciences, 1240(1): 26– 31. 22172036
  7. [7]Hansen KE, Kleker B, Safdar N, & Bartels CM (2014). A systematic review and meta-analysis of glucocorticoid-induced osteoporosis in children. Seminars in Arthritis and Rheumatism, 44(1): 47– 54. 24680381 PMC4119832
  8. [8]Weinstein RS (2011). Clinical practice. Glucocorticoid-induced bone disease. N Engl J Med, 365(1): 62– 70. 21732837
  9. [9]Hartmann K, Koenen M, Schauer S, Wittig-Blaich S, Ahmad M, Baschant U, & Tuckermann JP (2016). Molecular Actions of Glucocorticoids in Cartilage and Bone During Health, Disease, and Steroid Therapy. Physiological Reviews, 96(2): 409– 447. 26842265
  10. [12]Teitelbaum SL (2015). Glucocorticoids and the osteoclast. Clin Exp Rheumatol, 33(4 Suppl 92): S37– S39. 26458014
  11. [13]Weinstein RS (2010). Glucocorticoids, osteocytes, and skeletal fragility: The role of bone vascularity. Bone, 46(3): 564– 570. 19591965 PMC2823999
  12. [14]Wood CL, Soucek O, Wong SC, Zaman F, Farquharson C, Savendahl L, & Ahmed SF (2018). Animal models to explore the effects of glucocorticoids on skeletal growth and structure. Journal of Endocrinology, 236(1): R69– R91. 29051192
  13. [15]Ghali O, Broux O, Falgayrac G, Haren N, van Leeuwen J, Penel G, Hardouin P, & Chauveau C (2015). Dexamethasone in osteogenic medium strongly induces adipocyte differentiation of mouse bone marrow stromal cells and increases osteoblast differentiation. BMC Cell Biology, 16(1): 9. 25887471 PMC4359404
  14. [16]Yao W, Cheng Z, Busse C, Pham A, Nakamura MC, & Lane NE (2008). Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis: A longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice. Arthritis & Rheumatism, 58(6): 1674– 1686. 18512788 PMC3892702
  15. [17]Rauch A, Seitz S, Baschant U, Schilling AF, Illing A, Stride B, Kirilov M, Mandic V, Takacz A, & Schmidt-Ullrich R (2010). Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor. Cell Metab, 11(6): 517– 531. 20519123
  16. [18]O Brien CA, Jia D, Plotkin LI, Bellido T, Powers CC, Stewart SA, Manolagas SC, & Weinstein RS (2004). Glucocorticoids Act Directly on Osteoblasts and Osteocytes to Induce Their Apoptosis and Reduce Bone Formation and Strength. Endocrinology, 145(4): 1835– 1841. 14691012
  17. [19]Sato AY, Tu X, McAndrews KA, Plotkin LI, & Bellido T (2015). Prevention of glucocorticoid induced-apoptosis of osteoblasts and osteocytes by protecting against endoplasmic reticulum (ER) stress in vitro and in vivo in female mice. Bone, 73: 60– 68. 25532480 PMC4336847
  18. [21]Pierce JL, Ding K, Xu J, Sharma AK, Yu K, Del Mazo Arbona N, Rodríguez-Santos Z, Bernard PJ, Bollag WB, & Johnson MH (2019). The glucocorticoid receptor in osteoprogenitors regulates bone mass and marrow fat. Journal of Endocrinology, 243(1): 27– 42. PMC6938567 31370004
  19. [22]Sharma AK, Shi X, Isales CM, & McGee-Lawrence ME (2019). Endogenous Glucocorticoid Signaling in the Regulation of Bone and Marrow Adiposity: Lessons from Metabolism and Cross Talk in Other Tissues. Current Osteoporosis Reports, 17(6): 438– 445. 31749087
  20. [23]Goto H, Osaki M, Fukushima T, Sakamoto K, Hozumi A, Baba H, & Shindo H (2011). Human bone marrow adipocytes support dexamethasone-induced osteoclast differentiation and function through RANKL expression. Biomed Res, 32(1): 37– 44. 21383509
  21. [24]Hofbauer LC, Zeitz U, Schoppet M, Skalicky M, Schuler C, Stolina M, Kostenuik PJ, & Erben RG (2009). Prevention of glucocorticoid-induced bone loss in mice by inhibition of RANKL. Arthritis Rheum, 60(5): 1427– 1437. 19404943
  22. [25]Jia D, O’Brien CA, Stewart SA, Manolagas SC, & Weinstein RS (2006). Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density. Endocrinology, 147(12): 5592– 5599. 16935844 PMC1819400
  23. [26]Koedam JA, Smink JJ, & van Buul-Offers SC (2002). Glucocorticoids inhibit vascular endothelial growth factor expression in growth plate chondrocytes. Mol Cell Endocrinol, 197(1–2): 35– 44. 12431793
  24. [28]Yang P, Lv S, Wang Y, Peng Y, Ye Z, Xia Z, Ding G, Cao X, & Crane JL (2018). Preservation of type H vessels and osteoblasts by enhanced preosteoclast platelet-derived growth factor type BB attenuates glucocorticoid-induced osteoporosis in growing mice. Bone, 114: 1– 13. 29800693 PMC6309783
  25. [29]Kuo T, McQueen A, Chen TC, & Wang JC (2015). Regulation of Glucose Homeostasis by Glucocorticoids. Adv Exp Med Biol, 872: 99– 126. 26215992 PMC6185996
  26. [30]Peckett AJ, Wright DC, & Riddell MC (2011). The effects of glucocorticoids on adipose tissue lipid metabolism. Metabolism, 60(11): 1500– 1510. 21864867
  27. [31]Lee RA, Harris CA, & Wang JC (2018). Glucocorticoid Receptor and Adipocyte Biology. Nucl Receptor Res, 5. PMC6177265 30310815
  28. [32]Li J, Zhang N, Huang X, Xu J, Fernandes JC, Dai K, & Zhang X (2013). Dexamethasone shifts bone marrow stromal cells from osteoblasts to adipocytes by C/EBPalpha promoter methylation. Cell Death Dis, 4: e832. 24091675 PMC3824658
  29. [33]Rharass T, & Lucas S (2018). MECHANISMS IN ENDOCRINOLOGY: Bone marrow adiposity and bone, a bad romance? Eur J Endocrinol, 179(4): R165– R182. 30299886
  30. [35]He S, & Sharpless NE (2017). Senescence in Health and Disease. Cell, 169(6): 1000– 1011. 28575665 PMC5643029
  31. [36]Chang J, Wang Y, Shao L, Laberge R, Demaria M, Campisi J, Janakiraman K, Sharpless NE, Ding S, & Feng W (2016). Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice. Nature Medicine, 22(1): 78– 83. PMC4762215 26657143
  32. [39]He Y, Thummuri D, Zheng G, Okunieff P, Citrin DE, Vujaskovic Z, & Zhou D (2019). Cellular senescence and radiation-induced pulmonary fibrosis. Translational Research, 209: 14– 21. 30981698 PMC6857805
  33. [41]Muñoz-Espín D, & Serrano M (2014). Cellular senescence: from physiology to pathology. Nature Reviews Molecular Cell Biology, 15(7): 482– 496. 24954210
  34. [44]Coppé J, Desprez P, Krtolica A, & Campisi J (2010). The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor Suppression. Annual Review of Pathology: Mechanisms of Disease, 5(1): 99– 118. PMC4166495 20078217
  35. [45]Wiley CD, Sharma R, Davis SS, Lopez-Dominguez JA, Mitchell KP, Wiley S, Alimirah F, Kim DE, Payne T, & Rosko A (2021). Oxylipin biosynthesis reinforces cellular senescence and allows detection of senolysis. Cell Metab, 33(6): 1124– 1136. 33811820 PMC8501892
  36. [47]Liu JY, Souroullas GP, Diekman BO, Krishnamurthy J, Hall BM, Sorrentino JA, Parker JS, Sessions GA, Gudkov AV, & Sharpless NE (2019). Cells exhibiting strong p16 (INK4a) promoter activation in vivo display features of senescence. Proc Natl Acad Sci U S A, 116(7): 2603– 2611. 30683717 PMC6377452
  37. [48]Farr JN, Xu M, Weivoda MM, Monroe DG, Fraser DG, Onken JL, Negley BA, Sfeir JG, Ogrodnik MB, & Hachfeld CM (2017). Targeting cellular senescence prevents age-related bone loss in mice. Nature Medicine, 23(9): 1072– 1079. PMC5657592 28825716
  38. [50]Farr JN, Fraser DG, Wang H, Jaehn K, Ogrodnik MB, Weivoda MM, Drake MT, Tchkonia T, LeBrasseur NK, & Kirkland JL (2016). Identification of Senescent Cells in the Bone Microenvironment. J Bone Miner Res, 31(11): 1920– 1929. 27341653 PMC5289710
  39. [51]Saul D, Monroe DG, Rowsey JL, Kosinsky RL, Vos SJ, Doolittle ML, Farr JN, & Khosla S (2021). Modulation of fracture healing by the transient accumulation of senescent cells. Elife, 10. PMC8526061 34617510
  40. [52]Kumari R, & Jat P (2021). Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype. Front Cell Dev Biol, 9: 645593. 33855023 PMC8039141
  41. [53]van Deursen JM (2014). The role of senescent cells in ageing. Nature, 509(7501): 439– 446. 24848057 PMC4214092
  42. [54]Ambrosi TH, Scialdone A, Graja A, Gohlke S, Jank AM, Bocian C, Woelk L, Fan H, Logan DW, & Schurmann A (2017). Adipocyte Accumulation in the Bone Marrow during Obesity and Aging Impairs Stem Cell-Based Hematopoietic and Bone Regeneration. Cell Stem Cell, 20(6): 771– 784. 28330582 PMC5459794
  43. [55]Hu B, Lv X, Chen H, Xue P, Gao B, Wang X, Zhen G, Crane JL, Pan D, & Liu S (2020). Sensory nerves regulate mesenchymal stromal cell lineage commitment by tuning sympathetic tones. J Clin Invest. PMC7324175 32191640
  44. [57]Saul D, & Kosinsky RL (2021). Single-Cell Transcriptomics Reveals the Expression of Aging- and Senescence-Associated Genes in Distinct Cancer Cell Populations. Cells, 10(11). PMC8623328 34831349
  45. [58]Lanske B, & Rosen C (2017). Bone Marrow Adipose Tissue: The First 40 Years. Journal of Bone and Mineral Research, 32(6): 1153– 1156. 28370194 PMC5561657
  46. [59]de Paula F, & Rosen CJ (2020). Marrow Adipocytes: Origin, Structure, and Function. Annu Rev Physiol, 82: 461– 484. 31702948
  47. [60]Cawthorn WP, Scheller EL, Parlee SD, Pham HA, Learman BS, Redshaw CM, Sulston RJ, Burr AA, Das AK, & Simon BR (2016). Expansion of Bone Marrow Adipose Tissue During Caloric Restriction Is Associated With Increased Circulating Glucocorticoids and Not With Hypoleptinemia. Endocrinology, 157(2): 508– 521. 26696121 PMC4733126
  48. [61]Blackwell KA, Raisz LG, & Pilbeam CC (2010). Prostaglandins in bone: bad cop, good cop? Trends Endocrinol Metab, 21(5): 294– 301. 20079660 PMC2862787
  49. [62]Wiley CD, & Campisi J (2021). The metabolic roots of senescence: mechanisms and opportunities for intervention. Nat Metab, 3(10): 1290– 1301. 34663974 PMC8889622
  50. [63]Zdanov S, Bernard D, Debacq-Chainiaux F, Martien S, Gosselin K, Vercamer C, Chelli F, Toussaint O, & Abbadie C (2007). Normal or stress-induced fibroblast senescence involves COX-2 activity. Exp Cell Res, 313(14): 3046– 3056. 17560572
  51. [64]Kapadia R, Yi JH, & Vemuganti R (2008). Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists. Front Biosci, 13: 1813– 1826. 17981670 PMC2734868
  52. [65]Li J, Guo C, & Wu J (2019). 15-Deoxy--(12,14)-Prostaglandin J2 (15d-PGJ2), an Endogenous Ligand of PPAR-gamma: Function and Mechanism. PPAR Res, 2019: 7242030. 31467514 PMC6699332
  53. [66]Zhao X, Zhang Y, Strong R, Grotta JC, & Aronowski J (2006). 15d-Prostaglandin J2 activates peroxisome proliferator-activated receptor-gamma, promotes expression of catalase, and reduces inflammation, behavioral dysfunction, and neuronal loss after intracerebral hemorrhage in rats. J Cereb Blood Flow Metab, 26(6): 811– 820. 16208315
  54. [67]Wu W, Fu J, Gu Y, Wei Y, Ma P, & Wu J (2020). JAK2/STAT3 regulates estrogen-related senescence of bone marrow stem cells. J Endocrinol, 245(1): 141– 153. 32045363
  55. [68]Admasu TD, Rae M, & Stolzing A (2021). Dissecting primary and secondary senescence to enable new senotherapeutic strategies. Ageing Res Rev, 70: 101412. 34302996
  56. [72]Yu W, Zhong L, Yao L, Wei Y, Gui T, Li Z, Kim H, Holdreith N, Jiang X, & Tong W (2021). Bone marrow adipogenic lineage precursors promote osteoclastogenesis in bone remodeling and pathologic bone loss. J Clin Invest, 131(2). PMC7810488 33206630
  57. [73]Zhong L, Yao L, Tower RJ, Wei Y, Miao Z, Park J, Shrestha R, Wang L, Yu W, & Holdreith N (2020). Single cell transcriptomics identifies a unique adipose lineage cell population that regulates bone marrow environment. Elife, 9. PMC7220380 32286228
  58. [74]Zhong L, Yao L, Seale P, & Qin L (2021). Marrow adipogenic lineage precursor: A new cellular component of marrow adipose tissue. Best Pract Res Clin Endocrinol Metab, 35(4): 101518. 33812853 PMC8440665
  59. [76]Farr JN, Xu M, Weivoda MM, Monroe DG, Fraser DG, Onken JL, Negley BA, Sfeir JG, Ogrodnik MB, & Hachfeld CM (2017). Targeting cellular senescence prevents age-related bone loss in mice. Nat Med, 23(9): 1072– 1079. 28825716 PMC5657592
  60. [77]Li Z, Bagchi DP, Zhu J, Bowers E, Yu H, Hardij J, Mori H, Granger K, Skjaerlund J, & Mandair G (2022). Constitutive bone marrow adipocytes suppress local bone formation. JCI Insight, 7(21). PMC9675472 36048537
  61. [78]Qiu W, Sahin F, Iacobuzio-Donahue CA, Garcia-Carracedo D, Wang WM, Kuo CY, Chen D, Arking DE, Lowy AM, & Hruban RH (2011). Disruption of p16 and activation of Kras in pancreas increase ductal adenocarcinoma formation and metastasis in vivo. Oncotarget, 2(11): 862– 873. 22113502 PMC3259996
  62. [79]Ramasamy SK, Kusumbe AP, Wang L, & Adams RH (2014). Endothelial Notch activity promotes angiogenesis and osteogenesis in bone. Nature, 507(7492): 376– 380. 24647000 PMC4943529
  63. [80]Xie H, Cui Z, Wang L, Xia Z, Hu Y, Xian L, Li C, Xie L, Crane J, & Wan M (2014). PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis. Nature Medicine, 20(11): 1270– 1278. PMC4224644 25282358
  64. [81]Maridas DE, Rendina-Ruedy E, Le PT, & Rosen CJ (2018). Isolation, Culture, and Differentiation of Bone Marrow Stromal Cells and Osteoclast Progenitors from Mice. J Vis Exp(131). PMC5908449 29364278
  65. [82]Watanabe Y, Tsuchiya A, Seino S, Kawata Y, Kojima Y, Ikarashi S, Starkey LP, Lu WY, Kikuta J, & Kawai H (2019). Mesenchymal Stem Cells and Induced Bone Marrow-Derived Macrophages Synergistically Improve Liver Fibrosis in Mice. Stem Cells Transl Med, 8(3): 271– 284. 30394698 PMC6392382
  66. [84]Wang L, Chai Y, Li C, Liu H, Su W, Liu X, Yu B, Lei W, Yu B, & Crane JL (2018). Oxidized phospholipids are ligands for LRP6. Bone research, 6: 14– 22. 30038821 PMC6050227

Cited by

Sorted by citations

Authors
Liu, X., Gu, Y., Kumar, S., Amin, S., Guo, Q., Wang, J., Fang, C.-L., Cao, X., & Wan, M.
Affiliations
Johns Hopkins University (US)
Corresponding author
Wan, Mei
Venue
Cell Metabolism
Publisher
Elsevier BV
Published
2023-04
Volume
35
Issue
4
Pages
667-684.e6
ISSN
1550-4131 (ISSN-L)
OpenAlex
W4362604553
Cited by
137
References
87
Citations by year
2026: 57 · 2025: 36 · 2024: 32 · 2023: 12
FWCI
24.33
Type
journal article
Language
en
Open access
Locations
  • Cell Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Irving Medical Center, Columbia University
  • National Institutes of Health (P01AG066603, R01AG068226, R01AG072090)
  • Buck Institute for Research on Aging
Topics
  • Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
Keywords
glucocorticoid-induced osteoporosis, bone marrow adipocytes, cellular senescence, senescence-associated secretory phenotype, oxylipins, 15-deoxy-delta12-prostaglandin J2, PPARγ, p16INK4a, lipid metabolism, positive feedback loop
MeSH terms
Animals, Bone Marrow, Bone Marrow Cells, Glucocorticoids, Cellular Senescence, Adipocytes, PPAR gamma, Mice, Oxylipins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review